NCT01832948

Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer

Study of Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer and Efficacy Prediction

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Zhejiang Cancer Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study is to assess the efficacy and safety of Endostar combined with mFOLFOX6 in untreated metastatic colorectal cancer patients, and to find the markers that may predict the efficacy.

Conditions

• Metastatic Colorectal Cancer

Interventions

Type	Name	Description
DRUG	Endostar
DRUG	Oxaliplatin
DRUG	Folinic acid
DRUG	5-FU

Timeline

• Start date: 2013-01-01
• Primary completion: 2015-01-01
• Completion: 2015-01-01
• First posted: 2013-04-16
• Last updated: 2013-04-16

Locations

1 site across 1 country: China